1-1 of 1 results for subject:Streptococcus
Librarians' tools
- Search time
- 0.162 seconds
- Solr query time
- 0.002 seconds
- Search query
- subject:Streptococcus
- We searched for
- subject_t:Streptococcus OR subject_t:"Strep A" OR subject_t:"Streptococcal infections" OR subject_ses:368447
Type
House
Session
Year
Department
Member
Primary member
More
Answering member
Legislative stage
Legislation
Subject
Publisher
To ask the Secretary of State for Health and Social Care, what steps his Department is taking to improve (a) diagnosis and (b) treatment for Paediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal Infections.
To ask the Secretary of State for Health and Social Care, what steps his Department is taking to improve (a) diagnosis and (b) treatment for Paediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal Infections.
The Department recognises the importance of raising awareness of conditions such as paediatric acute-onset neuropsychiatric syndrome (PANS) and paediatric autoimmune neuropsychiatric disorder associated with streptococcus (PANDAS) among healthcare professionals, and improving the health and care system for the people living with them.
The National Institute for Health and Care Excellence (NICE) is the independent, expert body that develops evidence-based guidelines for the National Health Service on best practice. While the NICE currently has no plans to issue guidance on PANS and PANDAS, should the evidence base develop further, we would look to the NICE to update clinical policy.
In the meantime, integrated care systems are responsible for planning care for their populations’ conditions, and clinicians will want to take account of any new research and developments in guidance, such as those being overseen by the PANS PANDAS Steering Group, to ensure that they can continue to provide high quality care to their patients.